進階篩選

Technical category
技術研發單位
    • Blowing type of Ketone gas sensor applied in healthy care

      National Applied Research Laboratories FutureTech Blowing type of Ketone gas sensor applied in healthy care

      This technology is used micro-electro-mechanical systems combined nanomaterials and micro-heater systems, because the interdisciplinary integrated manufacturing technologies are used to make miniaturized sensor elements, which are equipped with bluetooth functions of algorithms and detection devices to monitor the ketones gas concentration during patient breathing applied in healthy care.
    • 同步之心電圖與窄頻照明微循環影像系統

      FutureTech 同步之心電圖與窄頻照明微循環影像系統

      This work synchronizes electrocardiograph to narrow-band imaging with high-power lens to observe the micro-circulation on the skin. The time difference among the arrivals of the cardiac pulse wave on different parts of the path is then used to calculate the pulse wave velocity of the arteries, providing very helpful diagnosis of diseases closely related to the peripheral circulation.
    • Peripheral Arterial Disease Screening System

      Bio-tech & New Drugs FutureTech Peripheral Arterial Disease Screening System

      In Taiwan, there are almost 96 million people look for medical treatment due to diabetes. The project successfully used the infrared light measurement system to observe the differences between the bilateral feet,collocating with the Chaos Synchronization to measure the differences between different signals, to decrease the probability of the attendance as the ultimate objective .
    • First-in-class anti-diabetic drug, PS1

      Precision Health Ecosystem FutureTech First-in-class anti-diabetic drug, PS1

      Diabetes is now still an incurable disease. Beta cell failure is one of common causes. No drugs for this failure have been developed. This invention is to developapply PS1 to treatreverse diabetes. PS1 is a first-in-class small-molecule drug, which targets beta cells by improving their survivalfunction. As a result, PS1 can treatreverse diabetes. The anti-diabetic mechanism of
    • Develop of novel anti-diabetic agents via targeting endogenous lipid mediators

      Bio-tech & New Drugs FutureTech Develop of novel anti-diabetic agents via targeting endogenous lipid mediators

      PPARγ is the master regulator of glucose metabolism.15-keto-PGE2 is an endogenous PPARγ ligand whitch is degraded by ZADH1. We found that increasing 15-keto-PGE2 promotes glucose uptake. We identified several ZADH1 inhibitors which could increase 15-keto-PGE2 promote glucose uptake via activating PPARγ. Our results showed that inhibition of ZADH1 is a novel approach to treat type 2 diabes mell
  • 1
本網站使用您的Cookie於優化網站。繼續瀏覽網站即表示您同意本公司隱私權政策,您可至隱私權政策了解詳細資訊。